Page last updated: 2024-10-30
beta-lapachone and Autosomal Dominant Striatonigral Degeneration
beta-lapachone has been researched along with Autosomal Dominant Striatonigral Degeneration in 1 studies
beta-lapachone: antineoplastic inhibitor of reverse transcriptase, DNA topoisomerase, and DNA polymerase
beta-lapachone : A benzochromenone that is 3,4-dihydro-2H-benzo[h]chromene-5,6-dione substituted by geminal methyl groups at position 2. Isolated from Tabebuia avellanedae, it exhibits antineoplastic and anti-inflammatory activities.
Research
Studies (1)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Lai, TS | 1 |
Liu, Y | 1 |
Tucker, T | 1 |
Daniel, KR | 1 |
Sane, DC | 1 |
Toone, E | 1 |
Burke, JR | 1 |
Strittmatter, WJ | 1 |
Greenberg, CS | 1 |
Other Studies
1 other study available for beta-lapachone and Autosomal Dominant Striatonigral Degeneration
Article | Year |
---|---|
Identification of chemical inhibitors to human tissue transglutaminase by screening existing drug libraries.
Topics: Animals; Calcium; Combinatorial Chemistry Techniques; Disease Models, Animal; Drosophila melanogaste | 2008 |